Sign inJoin waitlistJoin the waitlist

JT

Joseph Torkildson

Clinical Professor, Pediatrics · University of Arizona College of Medicine-Tucson

Credentials: · · ·

History

University of Arizona College of Medicine-Tucson
Present

University of Texas at San Antonio
2003
Pediatric Hematology Oncology
Children's Hospital Los Angeles
1987–1990
Naval Hospital
1982–1985
Medical College of Wisconsin
1978–1982

Research

Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy
Neuro-Oncology · 2017 · 207 citations
The genetic landscape of ganglioglioma
Acta Neuropathologica Communications · 2018 · 150 citations
Circulating erythroid progenitors in the anemia of prematurity
New England Journal of Medicine · 1987 · 95 citations

Anuradha Banerjee
7 papers
DS
David Samuel
7 papers
Sabine Mueller
7 papers
Arie Perry
5 papers
David Solomon
5 papers
James Grenert
5 papers
Andrew Bollen
4 papers · 4 as a fellow
Nalin Gupta
4 papers
Tarik Tihan
4 papers
Boris Bastian
3 papers
Cassie Kline
3 papers
CR
Corey Raffel
3 papers

Clinical trials

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2031
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
Site PI · Recruiting · Phase 2
Children's Oncology Group
2024–2027
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2029